Risk factors and predictors of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii mortality in critically ill bacteraemic patients over a 6-year period (2010–15): antibiotics do matter

Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia

(2016) Chang-Pan Liu et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies

(2016) Yu Zhang et al.   Emerging Microbes & Infections

The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit

(2015) Giancarlo Ceccarelli et al.   BMC INFECTIOUS DISEASES

Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii : Mechanisms and epidemiology

(2015) Anaïs Potron et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: A case control study

(2015) Sarunyou Chusri et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Increasing frequency of Pseudomonas aeruginosa infections during tigecycline use

(2015) Aysegul Ulu-Kilic et al.   Journal of Infection in Developing Countries

In vivoactivity of vancomycin combined with colistin against multidrug-resistant strains ofAcinetobacter baumanniiin aGalleriamellonellamodel

(2015) Haifei Yang et al.   Infectious Diseases

From ESKAPE to ESCAPE, From KPC to CCC

(2014) F. G. De Rosa et al.   CLINICAL INFECTIOUS DISEASES

Association of KPC-producing Klebsiella pneumoniae colonization or infection with Candida isolation and selection of non-albicans species

(2014) Matthaios Papadimitriou-Olivgeris et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Klebsiella pneumoniae Translocates across the Intestinal Epithelium via Rho GTPase- and Phosphatidylinositol 3-Kinase/Akt-Dependent Cell Invasion

(2014) Chun-Ru Hsu et al.   INFECTION AND IMMUNITY

Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries

(2014) M. Castanheira et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Warmer the Weather, the More Gram-Negative Bacteria - Impact of Temperature on Clinical Isolates in Intensive Care Units

(2014) Frank Schwab et al.   PLoS One

Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit

(2014) Matthaios Papadimitriou-Olivgeris et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Carbapenemase-producing Pseudomonas aeruginosafrom central Greece: molecular epidemiology and genetic analysis of class I integrons

(2013) Apostolos Liakopoulos et al.   BMC INFECTIOUS DISEASES

Clinical Efficacy and Safety of the Combination of Colistin plus Vancomycin for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii

(2013) José Garnacho-Montero et al.   CHEMOTHERAPY

Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy

(2012) Felipe F. Tuon et al.   Brazilian Journal of Infectious Diseases

Seasonality in Gram-negative and healthcare-associated infections

(2012) H. Richet   CLINICAL MICROBIOLOGY AND INFECTION

Spread of Multidrug-Resistant Pseudomonas aeruginosa Clones in a University Hospital

(2012) M. Koutsogiannou et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy

(2012) Youn Jeong Kim et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Impact of Carbapenem Resistance and Receipt of Active Antimicrobial Therapy on Clinical Outcomes of Acinetobacter baumannii Bloodstream Infections

(2011) John S. Esterly et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality

(2011) M. TUMBARELLO et al.   EPIDEMIOLOGY AND INFECTION

Predictors of mortality in surgical patients with Acinetobacter baumannii bacteremia

(2011) Su-Jung Chen et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Seasonal and Temperature-Associated Increases in Gram-Negative Bacterial Bloodstream Infections among Hospitalized Patients

(2011) Michael R. Eber et al.   PLoS One

Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients

(2010) Argyris Michalopoulos et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii

(2010) N. C. Gordon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Superinfection during treatment of nosocomial infections with tigecycline

(2010) E. García-Cabrera et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Sepsis Induces Early Alterations in Innate Immunity That Impact Mortality to Secondary Infection

(2010) M. J. Delano et al.   JOURNAL OF IMMUNOLOGY

International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

(2009) Jean-Louis Vincent   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL